SCHEMBL7678705

SCHEMBL7678705

CCC(C=O)c1ccc2ccccc2c1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
UGT2B7 P16662 1/20 0.47
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
ATM Q13315 1/20 0.45
CYP2D6 P10635 5/20 0.41
CYP1A2 P05177 2/20 0.41
AOC3 Q16853 2/20 0.41
TSHR P16473 1/20 0.41
HIF1A Q16665 1/20 0.41
CYP2A6 P11509 1/20 0.41
SLC6A2 P23975 6/20 0.40
SLC6A4 P31645 6/20 0.40
SLC6A3 Q01959 6/20 0.40
KCNH2 Q12809 5/20 0.40
CYP3A4 P08684 4/20 0.40
MMP9 P14780 1/20 0.40
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17892066 0.84 MEN1 (0.50) UGT2B7MEN1KMT2AATMCYP2D6
SCHEMBL11723402 0.83 AKR1B1 (0.55) UGT2B7MEN1KMT2ACYP2D6CYP1A2
SCHEMBL27602362 0.82 UGT2B7 (0.43) UGT2B7MEN1KMT2AATMCYP2D6
SCHEMBL7653484 0.82 UGT2B7 (0.47) UGT2B7MEN1KMT2AATMCYP2D6
SCHEMBL30434655 0.82 UGT2B7 (0.47) UGT2B7MEN1KMT2AATMCYP2D6
SCHEMBL11741624 0.81 AKR1C3 (0.57) CYP1A2TSHRCYP2A6AKR1C3AKR1C2
SCHEMBL218804 0.77 LMNA (0.46) MEN1KMT2ACYP2D6
SCHEMBL3276260 0.77 LMNA (0.46) MEN1KMT2ACYP2D6
SCHEMBL13452609 0.77 LMNA (0.46) MEN1KMT2ACYP2D6
SCHEMBL30366336 0.76 HDAC4 (0.42) TSHRHIF1ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380197-B1 FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES AVENTIS PHARMA S. A. (FR) 2002-04-30 US claimed
CN-114349687-B 3, 5-dicarboxylic ester-1, 4-dihydropyridine hydrogenation reagent, preparation method and application thereof 中山奕安泰医药科技有限公司 2023-11-17 CN disclosed
CN-114349685-B 1, 4-dihydropyridine hydrogenation reagent, preparation method and application thereof 中山奕安泰医药科技有限公司 2023-10-17 CN disclosed
CN-114349686-B 1, 4-dihydropyridine chiral hybrid hydrogenation reagent, preparation method and application thereof 中山奕安泰医药科技有限公司 2023-07-07 CN disclosed
WO-2022077851-A1 1,4-DIHYDROPYRIDINE CHIRAL HYBRID HYDROGENATION REAGENT, PREPARATION METHOD AND APPLICATION THEREOF 中山奕安泰医药科技有限公司 2022-04-21 WO disclosed
WO-2022077852-A1 3,5-DICARBOXYLIC ACID ESTER-1,4-DIHYDROPYRIDINE HYDROGENATING REAGENT, AND PREPARATION METHOD THEREFOR AND USE THEREOF 中山奕安泰医药科技有限公司 2022-04-21 WO disclosed
CN-114349687-A 3, 5-dicarboxylic ester-1, 4-dihydropyridine hydrogenation reagent and preparation method and application thereof 中山奕安泰医药科技有限公司 2022-04-15 CN disclosed
CN-114349686-A 1, 4-dihydropyridine chiral hybrid hydrogenation reagent and preparation method and application thereof 中山奕安泰医药科技有限公司 2022-04-15 CN disclosed
CN-114349685-A 3, 5-diamide-1, 4-dihydropyridine hydrogenation reagent and preparation method and application thereof 中山奕安泰医药科技有限公司 2022-04-15 CN disclosed
US-6380197-B1 FOR TREATING AND PREVENTING A PLETHORA OF DISEASES INCLUDING DIABETES AVENTIS PHARMA S. A. (FR) 2002-04-30 US disclosed